Skip to main content
SpringerLink
Log in

Obesity, sleep apnea, aldosterone, and hypertension

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

The pathogenesis of hypertension associated with obesity is unclear. This review provides evidence supporting excess visceral fat as an early aspect, and obstructive sleep apnea and elevated levels of aldosterone as factors closer to hypertension in the mechanistic chain. Features of visceral obesity and obstructive sleep apnea that may stimulate aldosterone secretion are described here. Possible therapeutic interventions addressing the hypertension associated with obesity are briefly mentioned.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Morse SA, Zhang R, Thakur V, Reisin E: Hypertension and the metabolic syndrome. Am J Med Sci 2005, 330:303–310.

    Article  PubMed  Google Scholar 

  2. Lambert E, Straznicky N, Schlaich M, et al.: Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007, 50:862–868.

    Article  PubMed  CAS  Google Scholar 

  3. Mancia G, Bousquet P, Elghozi JL, et al.: The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007, 25:909–920.

    Article  PubMed  CAS  Google Scholar 

  4. DiBona GF: dynamic analysis of patterns of renal sympathetic nerve activity: implications for renal function. Exp Physiol 2005, 90:159–161.

    Article  PubMed  Google Scholar 

  5. Correia ML, Haynes WG: Leptin, obesity and cardiovascular disease. Curr Opin Nephrol Hypertens 2004, 13:215–223.

    Article  PubMed  Google Scholar 

  6. Dancey DR, Hanly PJ, Soong C, et al.: Gender differences in sleep apnea: the role of neck circumference. Chest 2003, 123:1544–1550.

    Article  PubMed  Google Scholar 

  7. Morgan BJ: Pathophysiology of sleep apnea. In Hypertension Primer, edn 4. Edited by Izzo JL, Sica DA, Black HR. Philadelphia: Lippincott Williams and Wilkins; 2008:174–176.

    Google Scholar 

  8. Boggia J, Thijs L, Hansen TW, et al.: Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007, 370:1219–1229.

    Article  PubMed  Google Scholar 

  9. Norman D, Loredo JS, Nelesen RA, et al.: Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006, 47:840–845.

    Article  PubMed  CAS  Google Scholar 

  10. Hla KM, Skatrud JB, Finn L, et al.: The effect of correction of sleep-disordered breathing on BP in untreated hypertension. Chest 2002, 122:1125–1132.

    Article  PubMed  Google Scholar 

  11. Goodfriend TL, Calhoun DA: Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 2004, 43:1–7.

    Google Scholar 

  12. Egan BM, Stepniakowski K, Goodfriend TL: Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering. Am J Hypertens 1994, 7:886–893.

    PubMed  CAS  Google Scholar 

  13. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM: Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004, 125:112–117.

    Article  PubMed  CAS  Google Scholar 

  14. Aguilera G, Kiss A, Lu A, Camacho C: Regulation of adrenal steroidogenesis during chronic stress. Endocr Res 1996, 22:433–443.

    PubMed  CAS  Google Scholar 

  15. Hiramatsu K, Yamada T, Ichikawa K, et al.: Changes in endocrine activities relative to obesity in patients with essential hypertension. J Am Geriatr Soc 1981, 29:25–30.

    PubMed  CAS  Google Scholar 

  16. Rocchini AP, Katch VL, Grekin R: Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 1986, 57:613–618.

    Article  PubMed  CAS  Google Scholar 

  17. Goodfriend TL, Egan BM, Kelley DE: Aldosterone in obesity. Endocr Res 1998, 24:789–796.

    Article  PubMed  CAS  Google Scholar 

  18. Licata G, Volpe M, Scaglione R, Rubattu S: Salt-regulating hormones in young normotensive obese subjects: effects of saline load. Hypertension 1994, 23:I20–I24.

    PubMed  CAS  Google Scholar 

  19. Krieger J, Follenius M, Sforza E, et al.: Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci 1991, 80:443–449.

    PubMed  CAS  Google Scholar 

  20. Makhanova N, Hagaman J, Kim J-S, Smithies O: Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. Hypertension 2008, 51:134–140.

    Article  PubMed  CAS  Google Scholar 

  21. Nishizaka MK, Zaman MA, Calhoun DA: Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003, 16:925–930.

    Article  PubMed  CAS  Google Scholar 

  22. Ouzan J, Péraut C, Lincoff AM, et al.: The role of spironolactone in the treatment of patients with refractory hypertension. Am J Hypertens 2002, 15:333–339.

    Article  PubMed  CAS  Google Scholar 

  23. Stanley AG, Swales P, Thurston H, Williams B: Treating resistant hypertension in type 2 diabetes: a role for spironolactone. Br J Diabetes Vasc Dis 2006, 6:90–92.

    Article  Google Scholar 

  24. Sharabi Y, Adler E, Shamis A, et al.: Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension. Am J Hypertens 2006, 19:750–755.

    Article  PubMed  CAS  Google Scholar 

  25. Chapman N, Dobson J, Wilson S, et al.: Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 2007, 49:839–845.

    Article  PubMed  CAS  Google Scholar 

  26. Ritchie SA, Connell JM: The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007, 17:319–326.

    Article  PubMed  CAS  Google Scholar 

  27. Goodfriend TL, Egan B, Stepniakowski K, Ball DL: Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans. Hypertension 1995, 25:30–36.

    PubMed  CAS  Google Scholar 

  28. Vogt B, Bochud M, Burnier M: The association of aldosterone with obesity-related hypertension and the metabolic syndrome. Semin Nephrol 2007, 27:529–537.

    Article  PubMed  CAS  Google Scholar 

  29. Goodfriend TL: Aldosterone: a hormone of cardiovascular adaptation and maladaption. J Clin Hypertens 2006, 8:133–139.

    Article  CAS  Google Scholar 

  30. Adler GK, Williams GH: Aldosterone: villain or protector? Hypertension 2007, 50:31–32.

    Article  PubMed  CAS  Google Scholar 

  31. Fox CS, Massaro JM, Hoffmann U, et al.: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39–48.

    Article  PubMed  Google Scholar 

  32. Andrew R, Westerbacka J, Wahren J, et al.: The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes 2005, 54:1364–1370.

    Article  PubMed  CAS  Google Scholar 

  33. Kannisto K, Pietiläinen KH, Ehrenborg E, et al.: Over-expression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studied in young adult monozygotic twins. J Clin Endocrinol Metab 2004, 89:4414–4421.

    Article  PubMed  CAS  Google Scholar 

  34. Engeli S, Böhnke J, Feldpausch M, et al.: Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004, 12:9–17.

    Article  PubMed  CAS  Google Scholar 

  35. Paulsen SK, Pedersen SB, Fisker S, Richelsen B: 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 2007, 15:1954–1960.

    Article  CAS  Google Scholar 

  36. Goodfriend TL, Ball DL, Egan BM, et al.: Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 2004, 43[part 2]:358–363.

    Article  PubMed  CAS  Google Scholar 

  37. Schinner S, Willenberg HS, Krause D, et al.: Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. Int J Obes (Lond) 2007, 31:864–870.

    CAS  Google Scholar 

  38. Catena C, Lapenna R, Baroselli S, et al.: Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab 2006, 91:3457–3463.

    Article  PubMed  CAS  Google Scholar 

  39. Hitomu H, Kiyomoto H, Nishiyama A, et al.: Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells. Hypertension 2007, 50:750–755.

    Article  CAS  Google Scholar 

  40. Rondinone CM, Rodbard D, Baker ME: Aldosterone stimulates differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology 1993, 132:2421–2426.

    Article  PubMed  CAS  Google Scholar 

  41. Wolk R, Shamsuzzaman ASM, Somers VK: Obesity, sleep apnea, and hypertension. Hypertension 2003, 42:1067–1074.

    Article  PubMed  CAS  Google Scholar 

  42. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, et al.: Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007, 131:453–459.

    Article  PubMed  CAS  Google Scholar 

  43. Nagase M, Matsui H, Shibata S, et al.: Salt-induced nephropathy in obese spontaneously hypersensitive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 2007, 50:877–883.

    Article  PubMed  CAS  Google Scholar 

  44. Engeli S, Böhnke J, Gorzelniak K, et al.: Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005, 45:356–362.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Service, William S. Middleton Memorial Veterans Hospital, 2500 Overlook Terrace, Madison, WI, 53705, USA

    Theodore L. Goodfriend

Authors
  1. Theodore L. Goodfriend
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theodore L. Goodfriend.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goodfriend, T.L. Obesity, sleep apnea, aldosterone, and hypertension. Current Science Inc 10, 222–226 (2008). https://doi.org/10.1007/s11906-008-0042-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-008-0042-x

Keywords

Search

Navigation